Form 4: Agenus CEO Opts for Stock-Based Salary, Boosts Holdings

Agenus Inc.'s Chairman and CEO, Garo H. Armen, received 5,027 shares of common stock valued at $2.94 per share as salary, increasing his direct and indirect beneficial ownership.

Summary

• Garo H. Armen, Chairman, Chief Executive Officer, and Principal Financial Officer of Agenus Inc., acquired 5,027 shares of common stock.
• The shares were issued on February 6, 2026, at a price of $2.94 per share.
• This acquisition represents Dr. Armen's salary for the pay period ending February 6, 2026, paid in stock instead of cash, at his request and with Compensation Committee approval.
• Following this transaction, Dr. Armen directly owns 320,712 shares of Common Stock.
• Dr. Armen also indirectly owns 31,298 shares in his IRA accounts and 28,950 shares through the Garo Armen 2020 2 Year AG GRAT and Pixie Partners.
• The shares issued are fully vested on the date of issuance, in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. The CEO's choice to receive salary in stock indicates confidence in Agenus's future, aligning his financial interests directly with shareholder returns, which is generally well-received by investors.

Positives

• The CEO's decision to receive salary in stock demonstrates confidence in the company's future performance and aligns his interests with those of shareholders.
• The acquisition increases the CEO's direct beneficial ownership, signaling a stronger commitment to the company's long-term success.

Negatives

• Stock-based compensation, while aligning interests, can contribute to share dilution over time if not managed carefully, potentially impacting per-share value for existing shareholders.

Management Comments

• Garo H. Armen's salary is being paid in stock, in lieu of cash, at his request and with the approval of the Agenus Inc. Compensation Committee.

Industry Context

StockSavvy.ai notes that executive compensation in the form of company stock is a common practice across various industries, particularly in biotechnology and growth-oriented sectors. This strategy aims to align management incentives with shareholder value creation, as executives directly benefit from stock price appreciation. Such insider transactions are often viewed by the market as a signal of management's confidence in the company's future prospects.

Comparison to Industry Standards

• StockSavvy.ai notes that while stock-based compensation is a common practice for executive remuneration across various industries, this filing does not provide sufficient detail to compare specific compensation structures or share prices with direct competitors or industry benchmarks. However, the decision by a CEO to take salary in stock is generally seen as a positive alignment of interests, a practice observed in companies like Moderna (MRNA) or BioNTech (BNTX) where executive equity holdings are significant.

Corporate Governance

Related Party Transactions

• The payment of salary in common stock to Garo H. Armen, a director and officer, constitutes a related party transaction, approved by the Compensation Committee.

Stakeholder Impact

• Shareholders: May view the CEO's stock-based compensation as a positive signal of confidence and alignment of interests, potentially increasing investor trust. However, it also represents a minor dilution of existing shares.
• Employees: The compensation structure for the CEO may influence broader compensation strategies within the company, potentially signaling a shift towards more equity-based incentives.

Key Dates

Recommendation

While the CEO's decision to take salary in stock is a positive indicator of confidence, a single Form 4 filing detailing a routine compensation event is typically not sufficient to warrant a strong buy or sell recommendation. It reinforces a 'hold' stance for existing investors, suggesting management's belief in the company's value, but does not present new fundamental information to alter a broader investment thesis.

Keywords

Agenus Inc., AGEN, Garo H. Armen, Insider Trading, Form 4, Stock Compensation, Executive Compensation, Beneficial Ownership, Equity Incentive Plan